This move is archived. Current quotes and coverage live on the stock page.
Get HBP alerts:
Helix BioPharma Corp. has seen a notable surge in its stock price, closing up 5.63% in the last trading session.
In a positive turn of events for investors, Helix BioPharma Corp. (HBP.TO) experienced a significant boost in its stock price, closing at CA$1.50. This upward movement is noteworthy for a company navigating the complexities of the biotech sector.
Advertisement
Helix BioPharma Corp.
HBP.TO
HBP.TO
Helix BioPharma Corp.
WealthAwesomeMarket cap
$141.30M
52W high
$5.40
52W low
$1.10
1W change
-2.63%
Beta
-0.35
Analyst Price Targets
Based on analyst covering HBP
Wall Street analysts forecast HBP stock price to rise 35.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+35.1% Upside
Current Price
C$1.85
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HBP's historical volatility
30-Day Vol
67.2%
Annualized
90-Day Vol
65.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.21
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.96 | C$1.56 – C$2.48 |
| 60 trading days | C$2.08 | C$1.50 – C$2.89 |
| 90 trading days | C$2.21 | C$1.48 – C$3.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Helix BioPharma's recent stock performance highlights the potential for growth in the biotech sector, despite the challenges that small-cap companies often face.
Stock Price Climbs to CA$1.50
Helix BioPharma's stock has increased by 5.63% in one trading day, reflecting growing investor interest.
Bull case
The recent rise in Helix BioPharma's stock reflects positive investor sentiment. There’s excitement around potential announcements that could boost the company's standing in the market.
Bear case
Even with this positive movement, investors should stay cautious. Helix BioPharma hasn’t released any significant updates or financial results that could keep this momentum going in the long term.
Recent Performance Overview
Advertisement
Helix BioPharma Corp. has shown a robust performance in the last trading session, with a closing price of CA$1.50, marking a 5.63% increase. This surge reflects a growing interest in the company's potential within the biotech sector, despite its small market cap of approximately CA$108 million.
What’s Driving the Stock Surge?
While there are no major announcements or financial results from Helix BioPharma to explain the surge, the market often reacts positively to speculation and investor sentiment. The closure of a private placement of common shares earlier this month may have contributed to a more favorable outlook among investors, as it indicates the company's efforts to raise capital and support its development initiatives.
Looking Ahead
Investors should keep an eye on Helix BioPharma's future announcements and financial results. The biotech sector can be volatile, and while today's performance is encouraging, it is essential to consider the long-term viability of the company's projects and financial health. For more insights, visit our Helix BioPharma Corp. stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
